+ T cells. T ex cells are important clinical targets of checkpoint blockade and other immunotherapies. Epigenetically, T ex cells are a distinct immune subset, with a unique chromatin landscape compared with T eff and T mem cells. However, the mechanisms that govern the transcriptional and epigenetic development of T ex cells remain unknown. Here we identify the HMG-box transcription factor TOX as a central regulator of T ex cells in mice. TOX is largely dispensable for the formation of T eff and T mem cells, but it is critical for exhaustion: in the absence of TOX, T ex cells do not form. TOX is induced by calcineurin and NFAT2, and operates in a feed-forward loop in which it becomes calcineurin-independent and sustained in T ex cells. . T ex cells may balance partial pathogen or tumour control while restraining immunopathology. The consequence of restrained functionality, however, is disease persistence and/or progression 3,4 . T cell exhaustion is a common feature of many chronic infections and cancers in mice and humans [5][6][7][8] ; indeed, T ex cells are a major target of checkpoint blockade in patients with cancer 3,[9][10][11] . T ex cells are characterized by the hierarchical loss of cytokine production (IL-2, TNF, IFNγ), high co-expression of inhibitory receptors (such as PD-1, LAG-3, TIGIT), altered metabolism, and impaired proliferative potential and survival 2 . T ex cells also display a distinct transcriptional program that is highlighted by the altered use of key transcription factors 12 . Moreover, recent epigenetic analysis revealed that T ex cells differ from T eff and T mem cells by approximately 6,000 open chromatin regions [13][14][15][16] , which is similar to the differences between other major haematopoietic lineages 17 . T ex cells are therefore not simply a state of activation of T eff or T mem cells, but rather they are a distinct cell type. However, the mechanisms that initiate the fate commitment and epigenetic and transcriptional programming of T ex cells remain unknown.
. T ex cells may balance partial pathogen or tumour control while restraining immunopathology. The consequence of restrained functionality, however, is disease persistence and/or progression 3, 4 . T cell exhaustion is a common feature of many chronic infections and cancers in mice and humans [5] [6] [7] [8] ; indeed, T ex cells are a major target of checkpoint blockade in patients with cancer 3,9-11 . T ex cells are characterized by the hierarchical loss of cytokine production (IL-2, TNF, IFNγ), high co-expression of inhibitory receptors (such as PD-1, LAG-3, TIGIT), altered metabolism, and impaired proliferative potential and survival 2 . T ex cells also display a distinct transcriptional program that is highlighted by the altered use of key transcription factors 12 . Moreover, recent epigenetic analysis revealed that T ex cells differ from T eff and T mem cells by approximately 6,000 open chromatin regions [13] [14] [15] [16] , which is similar to the differences between other major haematopoietic lineages 17 . T ex cells are therefore not simply a state of activation of T eff or T mem cells, but rather they are a distinct cell type. However, the mechanisms that initiate the fate commitment and epigenetic and transcriptional programming of T ex cells remain unknown.
Here we identify a requisite role for the HMG-box transcription factor TOX in programming the early epigenetic events that drive the fate commitment of T ex cells. Although it is robustly expressed in T ex cells, TOX is only transiently expressed at low levels during acute infections. Moreover, T eff and T mem cells can form without TOX, whereas T ex cells cannot. TOX is necessary and sufficient to induce major features of T ex cells, including the expression of inhibitory receptors, decreased function and the expression of transcription factors that are required for T ex cells. TOX translates early, sustained NFAT2 activity into a subsequent calcineurin-independent TOX-driven molecular and epigenetic T ex program. Furthermore, TOX represses terminal T eff -cell-specific epigenetic events while initiating key T ex -cell-specific epigenetic changes. These data identify TOX as a critical transcriptional and epigenetic coordinator of T ex cell programming. Moreover, these observations have implications for the ontogeny of T ex cells and therapeutic opportunities.
Tox is selectively upregulated in developing T ex cells
We first analysed transcription data from virus-specific mouse CD8 + T cells responding to acute (Armstrong) or chronic (clone 13) lymphocytic choriomeningitis mammarenavirus (LCMV) infection. By day 6 post-infection, we detected considerable divergence of gene expression (Fig. 1a) . We proposed that genes that have chromatin-modulating capacity could drive distinct transcriptional trajectories in developing T mem and T ex cells. Indeed, gene ontology analysis identified differentially expressed gene families with chromatin-binding and transcription-factor activity (Fig. 1b) . Moreover, genes within these families were differentially engaged during T cell differentiation, suggesting distinct chromatin modulators that were involved in T eff , T mem and T ex cell Article reSeArcH differentiation (Fig. 1c, Extended Data Fig. 1a , Supplementary Table 1) . Genes in cluster 1 were biased to chronic infection and included those that encode several transcription factors (Stat1, Stat2, Tcf4, Ikzf2) and chromatin modulators (Tet2, Dnmt3a) with roles in T cell exhaustion 18, 19 , as well as genes with uncharacterized functions in T ex cells, including Setbp1, Kdm4a and Tox (Fig. 1d, Extended Data Fig. 1a, b ). Among these, Tox was the most differentially expressed in developing T ex cells when compared with T eff and T mem cells (Fig. 1e) .
TOX is involved in the development of natural killer, innate lymphoidlike, and CD4 + T cells 20, 21 . However, the role of TOX in peripheral CD8 + T cells is poorly understood. Previous network analyses found TOX to be the most differentially connected transcription factor between T mem and T ex cells, which suggests that it has a prominent role in T ex cells 12 . Moreover, chromatin accessibility of the Tox locus was increased in T ex compared to T eff cells, suggesting epigenetic remodelling of Tox in T ex cells (Fig. 1f) . The Tox locus contained a dense cluster of open chromatin regions, a feature associated with 'stretch' or 'super' enhancers 22, 23 . Such 'super' enhancers often demarcate genes or loci that are involved in cell fate decisions 23 . Among loci with large stretches of open chromatin, Tox ranked much more highly in T ex cells (rank = 35) compared to naive T, T eff and T mem cells (rank = 91, 365 and 64, respectively) (Extended Data Fig. 1c ). Together, these data lead to the hypothesis that TOX may act as a central node in the differentiation of T ex cells.
High and sustained TOX is associated with exhaustion
The expression of TOX significantly increased by day 4 of clone-13 infection, and approximately 80% of LCMV-specific P14 CD8 + T cells expressed high TOX by day 5 post-infection (Fig. 2a) . Moreover, high TOX expression was sustained in more than 95% of T ex cells from day 15 post-infection onwards, and it remained highly expressed for more than 200 days after infection (Fig. 2a, Extended Data Fig. 2a) . By contrast, although TOX was initially expressed in some T eff cells that responded to Armstrong infection, its expression peaked The table  (inset) enumerates differentially expressed genes (DEG; false discovery rate (FDR) < 0.05) between T cells during infection with Armstrong and clone 13 at the specified days post-infection. b, Gene ontology analysis of differentially expressed genes 6 days post-infection with Armstrong or clone 13. Grey and blue colours denote gene ontology molecular functions enriched in Armstrong and clone 13, respectively. Categories that include chromatin-binding proteins are highlighted in red. c, Heat map of differentially expressed chromatin-modulating genes (Supplementary   Table 8 , see Methods) between naive P14 T cells and P14 T cells during infection with Armstrong or clone 13. d, day. Genes are ordered by hierarchical clustering using Manhattan distance and clusters generated by k-means. Shown are the z-scores of log 2 expression data. d, Chromatin modulating genes in cluster 1. e, Difference in cumulative expression of genes in cluster 1. The values were calculated by summing the normalized array intensity of each gene at all time points post-infection and subtracting values from Armstrong infection from those of clone-13 infection. f, ATAC-seq tracks of in vivo naive T, T eff , T mem and T ex cells from P14 mice at the Tox locus. The accessibility index (AI) of each sample is calculated by summing the normalized tag counts across the locus and dividing by its length.
at 5-6 days post-infection and was limited to less than 25% of the population. Moreover, the amount of TOX per cell was low and expression was transient, returning to near-baseline levels between day 8-15 post-infection (Fig. 2a) . Thus, high and sustained levels of TOX were observed only during chronic infection. Notably, the difference in TOX expression emerged before the time at which the virological outcomes diverged (around 8 days post-infection) 24 , which suggests that viral load alone was not a primary driver of differential expression.
Whereas CD127 Fig. 2b ). This KLRG1
+ terminal effector population is unable to generate T ex cells, perhaps owing to a lack of TCF-1 and Eomes [27] [28] [29] . Indeed, TCF-1 and Eomes expression was confined mainly to the TOX + cells at day 8 post-infection (Fig. 2b, Extended Data Fig. 2c, top) . Although both TCF-1 subsets expressed TOX later in clone-13 infection, higher TOX correlated with higher Eomes 28 (Fig. 2b, Extended Data Fig. 2c , bottom). TOX + cells also had high expression of PD-1, TIGIT, LAG-3 and CD160 throughout clone-13 infection (Fig. 2c, Extended Data  Fig. 2d, e) . Therefore, TOX expression was negatively correlated with the development of KLRG1 + terminal T eff cells, and instead was associated with high expression of inhibitory receptors and key T ex cell transcription factors.
TOX expression in the setting of other acute infections was limited to the peak of the effector phase and rapidly decreased over time (Extended Data Fig. 2f ). By contrast, the majority of tumour-infiltrating CD8 + T lymphocytes (TILs) in B16F10 (B16) or CT26 tumours had high levels of TOX, and a high frequency of human melanoma TILs also expressed TOX (Extended Data Fig. 2g) . Additionally, the analysis of single-cell RNA expression data from TILs of patients with nonsmall-cell lung cancer or hepatocellular carcinoma showed that TOX expression was limited to the T ex cell subset (Extended Data Fig. 2h ). In TILs from mice and humans, there was a strong association between high TOX and high co-expression of inhibitory receptors (Fig. 2d , e, Extended Data Fig. 2g) . Finally, TOX expression in tumour-specific TILs was negatively associated with the production of inflammatory cytokines, which suggests that TOX may regulate T cell function in tumours (Extended Data Fig. 2i ).
An essential role for TOX in the generation of T ex cells
To further investigate the role of TOX in T ex cells, we generated Tox flox/flox Cd4 cre P14 mice (hereafter denoted TOX cKO). Naive T cells from TOX cKO P14 mice were mixed in a 1:1 ratio with T cells from wild-type P14 mice and adoptively transferred into new mice (Extended Data Fig. 3a, b) . In chronic infection, TOX cKO P14 T cells mounted an initial response, but then rapidly declined in number and were not sustained past day 15 post-infection, unlike wild-type P14 T cells that persisted (Fig. 3a, Extended Data Fig. 3c ). This decline was not due to rejection, because escaped TOX + cells could readily be detected long-term and both TOX cKO and wild-type P14 T cells initially proliferated similarly based on the analysis of Ki-67 (Extended Data Fig. 3d, e) . Moreover, TOX cKO cells that responded to acutely resolved LCMV Armstrong generated robust T eff and T mem cells that were detectable for more than 30 days (Fig. 3a) . Thus, TOX cKO CD8 + T cells were not intrinsically unable to form CD8 + T cells that could persist after acute infection, including T mem cells, but rather they had a specific defect in the ability to generate T ex cells.
TOX cKO P14 T cells generated more KLRG1 + CD127 − T eff cells in both acute and chronic infection (Fig. 3b, Extended Data Fig. 3f ). However, in Armstrong infection, TOX cKO cells effectively generated typical T mem cell populations (Extended Data Fig. 3g-k) . In chronic infection, TOX cKO cells expressed lower levels of PD-1, CD160, LAG-3 and TIGIT (Fig. 3c) . By contrast, levels of 2B4 and TIM-3 were increased in the absence of TOX, in agreement with previous studies that showed a negative correlation between PD-1 and TIM-3 early in clone-13 infection 30 (Fig. 3c) . TOX deficiency also improved function (Fig. 3d) . Because complete TOX deficiency resulted in an inability to sustain T ex cell responses, we next asked whether the conditional deletion of one allele would enhance tumour immunity. Indeed, partially TOX-deficient tumour-specific T cells controlled tumour growth significantly better than wild-type cells (Fig. 3e) .
The establishment and maintenance of T ex cells depends on a proliferative hierarchy mediated by TCF-1, T-bet and Eomes 28-30 . We therefore examined the expression of these transcription factors in the absence of TOX in T ex cells. The expression of Eomes was reduced in the absence of TOX, whereas that of T-bet was unaffected (Fig. 3f) . TCF-1 expression was nearly ablated in TOX cKO CD8 + T cells during chronic infection with a near absence of the TCF-1 + subset of T ex cells (Fig. 3f) . Notably, there was no defect in TCF-1 expression by naive TOX cKO cells, and TOX cKO T mem cells that were generated after acute infection retained the ability to express TCF-1 and Eomes (Extended Data Fig. 3b, h ). These data suggest that a primary defect in TOX cKO T ex cells is the inability to rewire the transcriptional control of TCF-1 and/or Eomes after initial development of T ex cell precursors, with a resulting loss of the TCF-1 + subset of T ex cells.
Transcriptional analysis of wild-type and Tox −/− P14 T cells on day 8 of clone-13 infection revealed the differential expression of more than 3,100 genes. A major feature of these data was the upregulation in TOXdeficient P14 T cells of many genes associated with T eff cells-including Klrg1, Gzma, Gzmb, Cx3cr1, Zeb2 and Prf1 (Fig. 3g , Supplementary as well as a number of genes associated with T cell or T ex cell progenitor biology including Myb, Il7r, Cxcr5, Slamf6, Lef1 and Tcf7 (Fig. 3g) . Indeed, in clone-13 infection in the absence of TOX, there was strong enrichment of the signature from T eff cells generated during LCMV Armstrong infection, whereas the signature of T ex cell precursors was depleted (Fig. 3h) . These data suggest that TOX is necessary to program early transcriptional responses to clone-13 infection. Moreover, the increased signature of short-lived KLRG1 + effectors that are incapable of giving rise to T ex cells could relate to increased TCR signalling due to reduced expression of inhibitory receptors in the absence of TOX 25, 26 ( Fig. 3i, Extended Data Fig. 3l, m) . Finally, enrichment of the T eff cell signature in Tox −/− cells was not due solely to the loss of Tcf7 expression, as only a minor proportion of the total transcriptional signature can be accounted for by the signature of Tcf7 −/− T cells 30 (Extended Data Fig. 3n ). Collectively, these findings suggest that TOX promotes the generation of T ex cells by fostering key developmental hallmarks of exhaustion while repressing development of the KLRG1 + T eff cell lineage.
Induction of TOX requires calcium signalling and NFAT2
In CD4
+

CD8
+ thymocytes, TOX expression depends on calcineurin signalling 31 . Indeed, the calcium ionophore ionomycin-which induces calcium flux and calcineurin signalling-induced TOX expression in naive CD8 + T cells, whereas treatment with the protein kinase C activator phorbol myristate acetate alone or in combination with ionomycin failed to induce TOX (Fig. 4a) 
z-score NES, normalized enrichment score. i, GSEA and normalized enrichment scores of transcriptional signatures associated with naive T, T eff or T mem cells compared to the differentially expressed genes in Tox −/− versus wild-type P14 T cells. Contour and histogram plots are representative of at least four independent experiments consisting of at least four mice. Heat maps were generated using z-scores derived from log 2 tag counts. Statistical significance (*P < 0.01) was determined using the Student's t-test, error is reported as s.d.
during clone-13 infection (Fig. 4d, Extended Data Fig. 4c ). NFAT2-deficient P14 T cells phenocopied TOX cKO P14 T cells and failed to generate T ex cell precursors, instead producing T eff cells with increased expression of KLRG1 and lower PD-1 and TCF-1 (Fig. 4d) . To complement the NFAT2 cKO approach, clone-13-infected mice containing wild-type P14 T cells were treated with the calcineurin inhibitor FK506 starting at day 3 post-infection. Treatment between day 3 and day 7 post-infection had a minimal effect on overall T cell activation, as measured by CD44 expression, but significantly reduced TOX expression (Fig. 4e, Extended Data Fig. 4d ). Moreover, P14 T cells from mice that were treated with FK506 phenocopied TOX-deficient T cells, based on the high expression of KLRG1, low expression of Eomes, and a lack of TCF-1 (Fig. 4e) . Retroviral expression of TOX in NFAT2-deficient T cells restored the expression of PD-1 and other inhibitory receptors, while increasing the expression of Eomes and TCF-1 and significantly reducing that of KLRG1 (Fig. 4f, Extended Data Fig. 4e ). Thus, calcineurin and NFAT2 are required to induce TOX. However, enforced TOX expression in NFAT2-cKO cells can restore early T ex differentiation, which demonstrates a key role for TOX as an inducer of T ex differentiation downstream of NFAT2.
We next tested whether continuous calcium and NFAT signalling were required for the sustained TOX expression once exhaustion was established. Treatment with FK506 or cyclosporin A between day 25 and day 29 of chronic infection reduced the expression of Ki-67 in T ex cells (Fig. 4g, Extended Data Fig. 4f, g ), as expected owing to the requirement of TCR signalling to drive the proliferative hierarchy of T ex cells 28 . Although the treatment of established T ex cells in vivo slightly enriched the progenitor T ex cell subset (TCF-1 high ), there was little effect on TOX expression and essentially all virus-specific T ex cells remained TOX + (Fig. 4g , Extended Data Fig. 4g ). Moreover, the expression of PD-1 and Eomes remained essentially unchanged (Fig. 4g , Extended Data Fig. 4g ). These data indicate that although initial TOX induction requires NFAT2, TOX expression and the TOX-dependent T ex cell program become independent of calcineurin signalling once established.
A program of exhaustion induced by TOX
We next tested whether TOX was sufficient to drive exhaustion. Retroviral TOX expression in vitro reduced cytokine production while increasing PD-1 (Fig. 5a, b ). To test whether these TOX-induced changes were durable in vivo, P14 T cells were transduced with Tox retrovirus and transferred into LCMV Armstrong-infected mice. In vivo, TOX expression reduced the frequency of KLRG1 + T eff cells, increased inhibitory-receptor expression, and reduced function (Extended Data Fig. 5a -c). Moreover, retrovirally expressed TOX reduced the expression of T-bet and increased that of TCF-1 (Extended Data Fig. 5d ). Thus, enforced TOX expression drove key features of T ex cells, skewed differentiation away from T eff and T mem cells, and sustained these effects for more than 30 days (Extended Data Fig. 5e Table 3) . Indeed, many key individual exhaustion genes-such as those encoding inhibitory receptors (Pdcd1, Lag3, Ctla4) and transcription factors (Nr4a2, Ikzf3, Tox2, Bhlhe41)-were induced by retrovirus-mediated TOX expression in vitro, whereas memory-associated genes (Ccr7, Il7r and Sell) were repressed (Fig. 5d) . Moreover, even in an unrelated cell type (NIH3T3 fibroblasts) TOX was found to induce expression of multiple immune pathways-including those associated with inflammatory cytokine production, T cell activation and proliferation as well as calcineurin and NFAT signalling (Fig. 5e, Extended Data Fig. 5h, i) . Additionally, the transcriptional signature induced by TOX in fibroblasts was enriched in the signature of in vivo T ex cells (Fig. 5f , Extended Data Fig. 5j, Supplementary Table 4) . Thus, TOX was capable of inducing a transcriptional program of T ex cells, and could even do so-at least partially-in an unrelated cell type. This is reminiscent of the related HMG transcription factor TCF-1, which can induce the expression of naive T cell genes in fibroblasts 37 .
Epigenetic programming of T ex cells by TOX
It has recently been demonstrated that T ex cells have a unique epigenetic landscape compared to naive T, T eff and T mem cells [13] [14] [15] [16] . Thus, we next asked whether TOX regulated this epigenetic commitment of T ex cells. In the absence of TOX there were around 4,000 regions for which chromatin accessibility was altered-as measured by an assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq)-on day 8 of clone-13 infection. Over 70% of these changes were in intronic or intergenic regions that were consistent with enhancers, whereas 20% were at promoters or transcription start sites (Extended Data Fig. 6a, Supplementary Table 5 ). Among these changes were increases in chromatin accessibility at genes associated with terminal T eff cell differentiation-including Klrg1, Gzma, Gzmb, Gzmm, Clnk, Zeb2 and Nr4a1 (Fig. 6a, b, Extended Data Fig. 6b )- Frequency of transduced T cells + P14 T cells on day 8 post-infection. e, TOX, KLRG1, PD-1 and TCF-1 expression in P14 T cells on day 8 post-infection with clone 13, after treatment with FK506 or PBS from day 3-7. f, NFAT2 cKO P14 T cells were transduced with a retrovirus (RV) encoding TOX (NFAT2 cKO + TOX) or control GFP (NFAT2 cKO + control) and adoptively transferred into wild-type congenic mice infected with clone 13. T eff markers, inhibitory receptors and transcription factors were evaluated on day 7 post-infection. g, Expression of T eff markers, inhibitory receptors and transcription factors measured on day 30 post-infection with clone 13 after treatment with FK506 or PBS on day 25-29. Contour and histogram plots are representative of at least three independent experiments consisting of at least three mice per group. Unless otherwise noted, P14 T cells were analysed from the spleens of infected mice. Statistical significance (*P < 0.01) was determined using the Student's t-test, error is reported as s.d.
Article reSeArcH which suggests that TOX represses the accessibility of genes involved in T eff cell differentiation. By contrast, loci with reduced chromatin accessibility included Tcf7 and other genes that are associated with T mem and T ex progenitors, including Ccr7, Slamf6, Bach2 and Ikzf2 (Fig. 6a, c,  Extended Data Fig. 6c) . Indeed, loci with significantly reduced chromatin accessibility in Tox −/− P14 T cells were highly enriched in T ex -cellspecific sites (647/1,697; 38%), whereas sites with increased chromatin accessibility were enriched in T eff -cell-specific sites (430/2,233; 19%) (Fig. 6d, Extended Data Fig. 6d) . Globally, the epigenetic signature of TOX-deficient P14 T cells at day 8 of chronic infection was strongly enriched in the T eff cell signature from acute infection and depleted in the T ex cell epigenetic signature (Fig. 6e, Extended Data Fig. 6e) . Moreover, specific peaks in the ATAC-seq profile were identified for key genes that changed in a TOX-dependent manner-including Klrg1, Zeb2 and Clnk, which became more accessible in the absence of TOX, and Tcf7, Bach2 and Ikzf2, for which the peaks were reduced or lost altogether (Fig. 6b, c, Extended Data Fig. 6b, c) . Notably, the epigenetic changes caused by TOX corresponded to functionally relevant events, because there was a strong association of chromatin opening with increased gene expression and vice versa (Extended Data Fig. 6f) . Thus, these data indicate a role for TOX in both the opening and closing of genomic regions associated with T ex or T eff cell differentiation, respectively.
We next examined epigenetic changes following the expression of TOX in isolated T cells from spleens (Fig. 5a ). Retrovirus-mediated TOX expression induced chromatin accessibility changes in 378 sites (Fig. 6f, Extended Data Fig. 6a, Supplementary Table 6 ). These epigenetic changes strongly enriched for the landscape observed in in vivo T ex cells, but also overlapped with the landscape found in T eff cells, possibly reflecting activation aspects of this short-term in vitro assay or highlighting the common epigenetic module shared between T ex and T eff cells 13, 14 (Fig. 6g, Extended Data Fig. 6g) . Moreover, at least one region opened by TOX was the T ex -cell-specific enhancer that is −23.8 kb upstream of the Pdcd1 transcription start site, which indicates that at least some exhaustion-specific epigenetic changes can be induced in vitro by TOX 13,14 (Extended Data Fig. 6h ). To investigate the mechanism by which TOX induced T ex -cell-related epigenetic changes, we identified proteins that were bound to TOX using immunoprecipitation followed by mass spectrometry (Extended Data Fig. 6i ). Mass spectrometry identified proteins involved in chromatin organization and remodelling, RNA processing and translation, as well as DNA replication as TOX binding partners (Extended Data  Fig. 6j, Supplementary Table 7 ). Network analysis identified the HBO1 complex, which is involved in the acetylation of histone H4 and H3, as a major set of TOX-bound proteins (Fig. 6h, i) ; indeed, four members of the histone H4-targeting HBO1 complex (KAT7, ING4, MEAF6 and JADE2) were identified by mass spectrometry 38,39 (Fig. 6h , i, Supplementary Table 7) . Co-immunoprecipitation confirmed that TOX interacted with KAT7, the acetyl transferase component of the HBO1 complex 38,39 (Fig. 6j) . TOX also bound proteins that are involved in repressive epigenetic events-including DNMT1, LEO1, PAF1, SAP130 and SIN3A-which indicates interactions with proteins that are involved in both the closing and the opening of chromatin (Fig. 6h,  Supplementary Table 7) . Thus, TOX can bind and probably recruit diverse sets of chromatin remodelling proteins.
Finally, we reasoned that TOX might modulate epigenetic accessibility and indirectly affect gene expression by altering the network of transcription factors and their targets in T ex cells. PageRank network analysis 40 of transcriptional and epigenetic data revealed that Tox −/− T cells were negatively enriched in multiple transcriptionfactor networks downstream of TCR signalling (Fos, Jun, Stat, Batf families), including NFAT2 (Fig. 6k) . Moreover, transcription-factor networks that are associated with transcriptional regulation (NR1D2, ATF3, BCL6 and SOX4) and the maintenance of cellular stemness (NANOG and SOX2) 41 were also lost in TOX-deficient T cells (Fig. 6k) . Together, these data suggest a model in which TOX-working with other transcription factors-is central to an epigenetic and transcriptional regulatory cascade that orchestrates the development of T ex cells.
Discussion
Here we demonstrate a major role for TOX as the key inducer of canonical features of T cell exhaustion and as an initiator of the T excell-specific epigenetic program. These findings have several potential implications. First, TOX expression and the molecular events that are controlled by TOX could aid in the more accurate detection, quantification and evaluation of T ex cells. Notably, recent mass cytometry studies of human CD8 + T cells found that TOX was expressed in the vast majority of T ex cells from patients with HIV and lung cancer 36 . Second, these studies point to key molecular underpinnings of exhaustion that are relevant for reversibility and re-invigoration by immunotherapies, including PD-1/PD-L1 blockade 3,10,11,13, [42] [43] [44] . TOX or TOX-dependent events-including epigenetic landscape programming-may be a major reason for this developmental inflexibility of T ex cells even after PD-1 blockade 13 , which suggests potential therapeutic strategies based on TOX manipulation. Finally, these data support the notion that T ex cells are a distinct cell type from T eff or T mem cells [13] [14] [15] [16] and provide a molecular mechanism for this divergent path of differentiation. T ex -associated genes from the leading edge of f labelled in red. f, As in c, genes uniquely upregulated (red) or downregulated (blue) in T ex cells were analysed for enrichment in TOX OE -transduced compared with controltransduced fibroblasts 36 . Contour and histogram plots are representative of at least three independent experiments. RNA sequencing datasets were generated from at least two biological replicates. Heat maps were generated using z-scores derived from log 2 tag counts. Statistical significance (*P < 0.01) was determined using the Student's t-test, error is reported as s.d.
Our observations suggest a model in which TOX is a primary regulator of T ex cells, similar to other developmental programmers in immune cells [45] [46] [47] [48] . Collectively, these data demonstrate that TOX is required for the development of T ex cells, although other transcription factors are clearly also involved. The identification of an epigenetic programming mechanism for T ex cells also suggests new therapeutic possibilities based on the modulation of TOX and/or the TOX-dependent epigenetic changes in T ex cells.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at https://doi.org/10.1038/ s41586-019-1325-x. WT   OTX2  FOXQ1  PAX6  CRX  PO5F1  NKX21  PO2F1  NKX31  SOX2  SMCA5  NANOG  MAF  SOX4  MAFG  BCL6  MAFF  MEIS2  STAT 6  NFAC1  GLI1  PO2F2  SUH  BATF  FOXJ3  TBX20  STAT 3  FOSB  JUND  FOS  FOSL1  HINFP  JUNB  BATF3  ATF3  NR1D1  NR1D2  ZN335  DDIT3  CEBPD  HNF6  RXRB  TWST1 −/− T cells at T ex -cell-specific and T eff -cell-specific chromatin accessibility peaks 13 . e, Chromatin regions specifically accessible in T ex cells 13 were analysed for enrichment in the Tox −/− versus wild-type P14 T cells by peak set enrichment analysis (PSEA). f, g, ATAC-seq analysis of in vitro T cells transduced with a retrovirus encoding TOX (TOX OE ) or control GFP.
f, Differentially accessible chromatin regions in TOX OE compared to control cells. g, PSEA of T ex -cell-specific loci as in e using differentially accessible loci in TOX OE versus control CD8 + T cells. h, MiST (mass spectrometry interaction statistics) score of proteins identified after TOX immunoprecipitation and mass spectrometry from EL4 lysate. The dashed line indicates high-confidence hits. i, STRING network analysis of proteins with a MiST score of >0.90. Gene ontology biological process (GO BP) analysis on a subsequent network is highlighted. j, Top, anti-TOX was used for the immunoprecipitation of TOX from EL4 lysate and blotted with anti-KAT7. Bottom, reverse immunoprecipitation was performed by immunoprecipitating with anti-KAT7, then blotting with anti-TOX. k, Heat map of transcription factors for which the PageRank score shows a difference of greater than 1.5-fold between wild-type and Tox −/− P14 T cells on day 8 of clone-13 infection. NFAC1 represents NFAT2. Heat maps were generated using z-scores derived from log 2 tag counts. Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. . For experiments with CT26 tumours, BALB/c mice from Charles River were used. For all experiments mice were age-and sex-matched and male and female mice between 6-8 weeks of age were randomly assigned to experimental groups. Naive lymphocyte isolation and adoptive T cell transfer. T cell receptor transgenic GP33-specific CD8 + T cells (P14) were isolated from the peripheral blood of donor mice using gradient centrifugation with Histopaque-1083 (Sigma-Aldrich). For experiments using LCMV infection, wild-type P14 T cells were mixed 1:1 with congenically disparate P14 T cells of the desired genotype (Tox ) and a total of 500 naive cells were adoptively transferred by tail-vein injection into 6-8-week-old recipient mice 1-5 days before infection. Recipients were of a third congenic background to enable us to distinguish both donor populations from the host T cells. Naive wild-type and TOX cKO P14 T cells had similar baseline activation and expression of inhibitory receptors, enabling a direct comparison (Extended Data Fig. 3b ). For experiments that monitored only wild-type P14 responses, 500 cells were transferred. Previous reports have shown that adoptive transfer of 500 P14 T cells before infection with LCMV clone 13 or Armstrong does not affect viral load or pathogenesis 4, 50, 51 . For LCMV experiments, mice were not depleted of CD4 + T cells using GK1.5 antibody before infection. For experiments with influenza, Listeria monocytogenes or vesicular stomatitis virus infection (VSV), 5,000 P14 T cells (influenza,
Methods
L. monocytogenes) or OT-I (VSV) CD8
+ T cells were adoptively transferred before infection. Viral infections, bacterial infections, and treatments. LCMV strains Armstrong and clone 13 were propagated and titres were determined as previously described 51 . C57BL/6J mice were infected intraperitoneally with 2 × 10 5 plaque-forming units (PFU) of LCMV Armstrong or intravenously with 4 × 10 6 PFU LCMV clone 13. For other experiments, mice were infected with 2 × 10 6 PFU VSV-OVA (intravenously) or 1 × 10 4 colony-forming units (CFU) L. monocytogenes GP33 intraperitoneally. For influenza infection, mice were anaesthetized with isofluorane and ketamine before intranasal administration of 50 TCID 50 PR8-GP33 (H1N1 strain) in 30 μl of PBS. FK506 (Prograf, Astellas Pharma) was prepared for injection by diluting to 1.5 mg ml −1 in PBS. Diluted FK506 was administered subcutaneously at a dose of 10 mg kg −1 from day 3-7 or day 25-29 of LCMV clone-13 infection 52 . Cyclosporin A (Sigma-Aldrich) was prepared by dilution in sunflower oil (Sigma-Aldrich). A diluted solution (40 mg kg −1 ) was administered intraperitoneally each day for the duration of treatment. For control treatments, PBS was administered subcutaneously.
Retroviral transduction, in vitro differentiation and cell transfer. For retroviral transduction, CD8
+ T cells were enriched from the spleens of donor mice using an EasySep magnetic negative selection kit (Stem Cell Technologies) and transduced as described previously 53 . In brief, cells were resuspended at 10 6 per ml in complete RPMI (cRPMI): RPMI 1640 supplemented with 10% FBS, 50 μM β-mercaptoethanol, 100 U ml −1 penicillin, 100 U ml −1 streptomycin, non-essential amino acids (Invitrogen), sodium pyruvate (Invitrogen) and HEPES buffer (Invitrogen). T cells (3 × 10 6 ) were plated in wells of a 12-well cluster dish and activated for 18-24 h with 1 μg ml −1 anti-CD3ε (145-2C11, BioLegend) and 0.5 μg ml −1 anti-CD28 (37.51, BioLegend) antibodies in the presence of 100 U ml −1 recombinant human IL-2 (Peprotech). After activation, cells were resuspended at 3 × 10 6 per ml in cRPMI, plated in a well of a six-well plate and transduced with MigR1-based retroviruses in the presence of polybrene (4 μg ml ) by spin infection (2,000g for 75 min at 32 °C). Retroviral supernatants were produced by co-transfecting HEK293T cells with a retrovirus expression plasmid and a pCL-Eco packaging plasmid using Lipofectamine 3000 (Invitrogen).
For in vitro experiments, transduced T cells were expanded and differentiated into effector T cells 33 by culturing in cRPMI in the presence of IL-2 (100 U ml , 37.51, BioLegend) antibodies for 5 min followed by the addition of 25 μg ml −1 streptavidin (Invitrogen) for 5 h in a 37 °C incubator. For experiments involving the transfer of transduced P14 T cells into mice, the mice were infected with LCMV Armstrong or clone 13 on the same day as transduction. Twenty-four hours after transduction, GFP + cells were sorted to >98% purity and transferred intravenously into infected hosts.
Ectopic tumour models, cell transfers and area measurements. B16-F10, B16-F10-GP33 melanoma, and CT26 colon carcinoma cell lines were purchased from ATCC. Tumour cells were maintained at 37 °C in DMEM medium supplemented with 10% FBS, 100 U ml −1 penicillin, 100 U ml −1 streptomycin and 2 mM l-glutamine. Tumour cells (2 × 10 5 ) were injected subcutaneously into the flanks of mice. To measure antigen-specific T cell responses, P14 T cells were isolated from spleens of naive mice and activated as described above for retrovirus transduction. Activated cells were passaged every 24 h and plated at 3 × 10 6 in 3 ml cRPMI with 100 U ml −1 recombinant human IL-2 per well of a six-well plate. Seventy-two hours after activation, 1 × 10 6 cells were transferred intravenously per tumour-inoculated mouse. T cell transfers were performed 5 days after tumour inoculation. Tumour size was measured using digital calipers every 48 h after inoculation. Plasmids and cloning. Retroviral vectors encoding TOX were generated by first amplifying Gateway cloning compatible inserts from an ORF clone (Origene MR208435). PCR products were purified (PCR Purification Kit, Qiagen) and subcloned into pDONR221 using BP clonase (Invitrogen) following the manufacturer's instructions. Entry clones were subsequently cloned into a Gatewaycompatible MigR1 vector using LR clonase (Invitrogen). Wild-type-NFAT2 and CA-NFAT2 retrovirus plasmids were gifts from A. Rao (Addgene plasmids 11101 and 11102).
Preparation of cell suspensions and restimulations. After infection or tumour challenge, CD8
+ T cells were isolated from spleen and draining lymph nodes by cutting samples into small pieces and homogenizing against a 70-μm cell strainer. Cells were run through the cell strainer and red blood cells were lysed in ACK lysis buffer (Thermo Fisher Scientific) for 5 min. The cell suspension was then washed in PBS and passed through a 70-μm cell strainer once more. Lungs and tumours were cut into small pieces using surgical scissors and digested for 1 h at 37 °C in RPMI 1640 medium supplemented with 5% FBS, 100 U ml −1 DNaseI (Sigma-Aldrich) and 0.2 mg ml −1 collagenase IV (Sigma-Aldrich). Samples were subsequently mechanically disrupted against a 70-μm filter and washed with PBS. Red blood cells were lysed in ACK lysis buffer for 5 min and samples were refiltered through a 70-μm strainer. To assess cytokine and effector molecule production, 2 × 10 6 cells were plated in 200 μl cRPMI in wells of a flat-bottom 96-well dish and incubated with GP33 peptide in the presence of protein transport inhibitors (GolgiStop and GolgiPlug, BD Biosciences) for 5 h at 37 °C. Human sample collection and staining. Normal donor peripheral blood samples (n = 10, male and female donors, aged 18-39) were obtained from Cellular Technology. Human melanoma tumour and peripheral blood mononuclear cell samples were collected from patients with stage III and stage IV melanoma under the University of Pennsylvania Abramson Cancer Center's melanoma research program tissue collection protocol UPCC 08607 and IRB 703001 in accordance with the Institutional Review Board. Tumour samples were procured from the operating room and processed the same day using manual dissociation into a single-cell suspension. Tumour samples were then frozen immediately using standard freezing media, and stored in liquid nitrogen. All human samples were processed and stained as previously described 54 . Flow cytometry and cell sorting. Antibodies were procured from the following sources: BioLegend: CD44 (IM7), CD62L (MEL-14), CD127 (A7R34), T-bet (4B10), PD-1 (RMP1-30), CD160 (7H1), TIM-3 (RMT3-23), CD3ε (17A2), TNF (MP6-XT22), CD8α (53-6.7), CD4 (RM4-5), CD45.1 (A29), CD45.2 (104); Miltenyi Biotec: TOX (REA473); Southern Biotech: KLRG1 (2F1); eBioscience: Eomes (Dan11mag), 2B4 (eBio244F4), IFNγ (XMG1.2), granzyme B (GB11), B220 (RA3-6B2); BD Biosciences: TIGIT (1G9), LAG-3 (C9B7W), TCF-1 (S33-966), 2B4 (2B4), Ki-67 (B56). Live cells were discriminated by staining with Zombie NIR dye (BioLegend). Intracellular and nuclear staining of cytokines, effector molecules and transcription factors was performed using the FoxP3/Transcription Factor Staining Buffer Set (eBioscience) in accordance with the manufacturer's protocol. Flow cytometry data were acquired on a BD LSR II instrument and cell sorting was performed on a BD FACSAria enclosed within a laminar flow hood. Data were analysed using FlowJo software (TreeStar).
Microarray analysis. Microarray data (GSE41867)
12 were processed as previously described 12, 13 . Genes with chromatin-modulating function were identified by compiling gene lists retrieved from gene ontology associations (GO molecular functions: chromatin binding, nucleic-acid binding, nucleotide binding; and PANTHER protein classes: DNA-binding protein, chromatin-binding protein), the EpiFactors database 55 and previously identified chromatin modulators 56 (Supplementary Table 9 ). RNA-seq and ATAC-seq sample preparation and sequencing. To assess the transcriptional and epigenetic effect of TOX deletion in T cells, 250 wild-type and 250 Tox −/− naive CD44 low CD62L high P14 T cells sorted from peripheral blood of donors, mixed and co-transferred into wild-type mice. Recipients were subsequently infected with LCMV clone 13 and splenocytes were collected 8 days after infection. Ten spleens were pooled for each of the three replicates before processing, CD8
+ T cell enrichment (using EasySep CD8 + T cell negative selection Article reSeArcH kit, Stem Cell Technologies), and staining of single-cell suspensions. Wild-type and TOX-deficient P14 T cells (1 × 10 5 ) were sorted to a purity of >98% for each replicate. In ectopic and enforced expression experiments, in vitro differentiated CD8 + T cells transduced with TOX + GFP or control GFP only (>2 biological replicates each) were sorted on GFP expression 6 days after initial activation to a purity of >98%. NIH3T3 cells were transduced with TOX + GFP or control GFP-only retroviruses and cultured for 48 h before cell sorting. To extract RNA, 50,000 cells were resuspended in RLT buffer supplemented with β-mercaptoethanol and processed with a RNeasy Micro Kit (Qiagen) as per the manufacturer's instructions. Total RNA libraries were prepared using a Pico Input SMARTer Stranded Total RNA-Seq Kit (Takara). Extracted RNA and libraries were assessed for quality on a TapeStation 2200 instrument (Agilent). ATAC libraries were generated as described with minor modifications 57 . In brief, nuclei from 50,000 cells were isolated using a lysis solution composed of 10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl 2 , and 0.1% IGEPAL CA-630. Immediately after cell lysis, nuclei were pelleted in low-bind 1.5-ml tubes (Eppendorf) and resuspended in TD buffer with Tn5 transposase (Illumina). The transposition reaction was performed at 37 °C for 45 min. DNA fragments were purified from enzyme solution using MinElute Enzyme Reaction Cleanup Kit (Qiagen). Libraries were barcoded (Nextera Index Kit, Illumina) and amplified with NEBNext High Fidelity PCR Mix (New England Biolabs). Library quality was assessed using a TapeStation instrument. RNA and ATAC libraries were quantified using a KAPA Library Quantification Kit and sequenced on an Illumina NextSeq 550 instrument (150 bp, paired-end) on high-output flow cells. RNA-seq data processing and analysis. FASTQ files were aligned using STAR 2.5.2a against the mm10 mouse reference genome. The aligned files were processed using PORT gene-based normalization (https://github.com/itmat/Normalization). Differential gene expression was performed with Limma. Limma-voom was used to identify transcripts that were significantly differentially expressed between experimental groups using an adjusted P value of <0.05. ATAC-seq data processing and analysis. The script used for processing raw ATAC-seq FASTQ data are available at the following GitHub repository: https://github.com/wherrylab/jogiles_ATAC. In brief, samples were aligned to the mm10 reference genome with Bowtie2. Unmapped, unpaired and mitochrondrial reads were removed using samtools. ENCODE Blacklist regions were removed (https://sites.google.com/site/anshulkundaje/projects/blacklists). PCR duplicates were removed using Picard. Peak calling was performed with MACS2 with a FDR q-value of 0.01. A union peak list for each experiment was created by combining all peaks in all samples; overlapping peaks were merged using bedtools merge. The number of reads in each peak was determined with bedtools coverage. Differentially expressed peaks were identified after DESeq2 normalization using a FDR cut-off of <0.05.
Super enhancers were identified by running the ROSE algorithm (https:// bitbucket.org/young_computation/rose) on normalized ATAC-seq data previously generated from naive, effector, memory or exhausted CD8 + T cells 13 . The stitching distance was set to 12.5 kb and transcription-start-site exclusion to 2.5 kb.
The scripts for peak set enrichment are available at https://github.com/ wherrylab/jogiles_ATAC. In brief, bedtools intersect was used to find overlapping peaks between the experiment and the peak set of interest. Peak names between the experiment and peak set of interest were unified using custom R scripts. GSEA was used to calculate enrichment scores. Taiji/PageRank network analysis. The Taiji pipeline integrates diverse datasets to identify master regulators, including genome-wide expression profile and chromatin state. Analysis was performed on RNA-seq and ATAC-seq data generated from wild-type and Tox −/− P14 T cells after 8 days of infection with clone 13 (as described in Figs. 3 and 6, respectively) . Herein, we implemented the pipeline described previously (http://wanglab.ucsd.edu/star/taiji) 40 . In brief, ATAC-seq peaks were called by MACS2 v.2.1.1 to annotate genome-wide regulatory elements and the regulatory elements are assigned to their nearest genes. Known transcription-factor motifs are scanned in the open chromatin region within each regulatory element to pinpoint the putative binding-sites. Transcription factors with putative binding-sites in promoters or enhancers are then linked to their target genes to form a network. As part of Taiji pagerank analysis, a personalized PageRank algorithm is used to assess the importance of transcription factors in the network and ranks are calculated for each transcription factor on the basis of epigenetic and RNA expression data. The normalized ranks are then compared across conditions by calculating fold change and the top transcription factors are chosen using a cut-off of 1.5× above the mean. These transcription factors are finally visualized in a heat map. Immunoprecipitation and immunoblotting. Immunoprecipitation was performed as previously described 58 . In brief, 5 × 10 6 EL4 cells were lysed in immunoprecipitation buffer (20 mM Tris, pH 7.5, 137 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 1% NP-40, 10% glycerol) supplemented with 1:100 HALT protease and phosphatase inhibitor cocktail (Thermo Scientific) and benzonase (Novagen) at 12.5 U ml −1 . Lysates were rotated at 4 °C for 60 min. Subsequently, antibodyconjugated Dynabeads (Invitrogen) were added and samples were incubated at 4 °C overnight on a rotating platform. Beads were collected using a magnet and samples were washed five times with immunoprecipitation buffer. Samples were then resuspended in NuPAGE loading dye (Thermo Fisher), incubated at 95 °C for 5 min and analysed by western blotting. The following antibodies were used for immunoprecipitation: TOX (ab155768, Abcam) and KAT7 (ab70183, Abcam); and for western blot: TOX (TXRX10, eBioscience), KAT7 (ab70183, Abcam), H3K4me1 (ab8895, Abcam), H3K27me3 (ab6002, Abcam), H3K9ac (39918, Active Motif), H3K27ac (ab4729, Abcam), H4 (07-108, Millipore) and H4ac (06-866, Millipore). Immunoprecipitation, LC-MS/MS and analysis. We used EL4 thymoma cells that express high levels of TOX and have been used previously to model some features of T ex cells 14 . EL4 cell nuclear extract was prepared as described 59 . In brief, cells were incubated in hypotonic buffer (10 mM Tris-Cl, pH 7.4, 1.5 mM MgCl 2 , 10 mM KCl, 25 mM NaF, 1 mM Na 3 VO 4 , 1 mM dithiothreitol (DTT) and Roche protease inhibitor cocktail) for 3 min. Cell pellets were subsequently spun down, resuspended in hypotonic buffer, and homogenized with five strokes of a Dounce homogenizer. Nuclei were collected by centrifugation and resuspended in extraction buffer (50 mM Tris-Cl, pH 7.4, 1.5 mM MgCl 2 , 20% glycerol, 420 mM NaCl, 25 mM NaF, 1 mM Na 3 VO 4 , 1 mM DTT, 400 U ml −1 DNase I and protease inhibitor cocktail). Samples were incubated for 30 min at 4 °C on a rotating plat form. Extracts were diluted 3:1 in buffer containing 50 mM Tris-Cl, pH 7.4, 1.5 mM MgCl 2 , 25 mM NaF, 1 mM Na 3 VO 4 , 0.6% NP-40, 1 mM DTT and protease inhibitor cocktail. Immunopurification was carried out on 1 mg of nuclear extract using a magnetic co-immunoprecipitation kit (Thermo Fisher) with 40 μg anti-TOX (Abcam, ab155768) or control IgG antibody as per the manufacturer's instructions.
Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) analysis was performed by the Proteomics and Metabolomics Facility at the Wistar Institute using a Q Exactive Plus mass spectrometer (Thermo Fisher) coupled with a Nano-ACQUITY UPLC system (Waters). Samples were digested in-gel with trypsin and injected onto a UPLC Symmetry trap column (180 μm i.d. × 2 cm packed with 5 μm C18 resin; Waters). Tryptic peptides were separated by reversedphase HPLC on a BEH C18 nanocapillary analytical column (75 μm i.d. × 25 cm, 1.7 μm particle size; Waters) using a 95 min gradient formed by solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in acetonitrile). A 30-min blank gradient was run between sample injections to minimize carryover. Eluted peptides were analysed by the mass spectrometer set to repetitively scan m/z from 400 to 2,000 in positive-ion mode. The full MS scan was collected at 70,000 reso lution followed by data-dependent MS/MS scans at 17,500 resolution on the 20 most abundant ions exceeding a minimum threshold of 20,000. Peptide match was set as preferred, exclude isotopes option and charge-state screening were enabled to reject singly and unassigned charged ions. Peptide sequences were identified using MaxQuant 1.5.2.8. MS/MS spectra were searched against a UniProt human protein database using full tryptic specificity with up to two missed cleavages, static carboxamidomethylation of Cys, and variable oxidation of Met and protein N-terminal acetylation. Consensus identification lists were generated with FDRs of 1% at protein and peptide levels. To generate a list of statistically significant hits, the resulting iBAQ protein values from the MaxQuant output were analysed using the MiST scoring system 60 , which accounts for protein abundance, specificity and reproducibility across three biological replicates. STRING protein-protein network analysis was performed on proteins with a MiST score of >0.90 using an interaction score of 0.4 (medium). Statistical analysis. Statistical tests for flow-cytometry data were performed using GraphPad Prism software. A P value of <0.05 was considered significant in these analyses. A Student's t-test (two-tailed) was used for comparisons between two independent conditions. A paired Student's t-test was used when the samples being compared originated from the same mouse. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
RNA-seq and ATAC-seq data have been deposited in the NCBI Gene Expression Omnibus (GEO) database and are accessible through the GEO SuperSeries accession number: GSE131871. All other relevant data are available from the corresponding author upon reasonable request.
Code availability
Custom code used for RNA-seq and ATAC-seq analyses are available at the GitHub links provided above. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested 
Data analysis
Flow cytometry data were analyzed on FlowJo v10.4.2 (TreeStar) and statistical analysis performed on Prism v6.0 (GraphPad). Genomic analyses were performed using R Studio v3.4.3 and all packages utilized were updated to most current versions. Custom script locations have been noted in the methods section.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
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Sample size
Sample sizes were based on those used in previous and preliminary studies from our lab. For all animal experiments, we expected to see at least a ~50% difference relative to control populations. Therefore, sample sizes of n=3-7 were chosen to allow for the determination of this difference (t-test, α set at 0.05). Additional 1-3 mice were used per experimental group for LCMV and LM infection experiments to compensate for mortality.
Data exclusions No data were excluded from analyses
Replication
All experiments presented in this study were performed using at least 2 biological replicates. All presented results were repeatable.
Randomization Adoptive transfer and infection experiments were randomized by selecting recipient mice at random from a pool of >8 for each experiment.
Blinding
Blinding was not relevant to these studies
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